NCT07191756 - Amphotericin B Versus Isavuconazole for Mucormycosis: A Comparative Efficacy and Safety Study | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

May 15, 2025

Primary Completion Date

July 21, 2025

Study Completion Date

September 25, 2025

Conditions

Mucormycosis

Interventions

DRUG

Amphotericin B

This is a retrospective observational study. Patients in this cohort received various formulations of amphotericin B as part of their standard medical care.

DRUG

Isavuconazole

This is a retrospective observational study. Patients in this cohort received isavuconazole as part of their standard medical care.

Trial Locations (1)

Unknown

Guangxi Medical University, Nanning

All Listed Sponsors

collaborator

Guangzhou Medical University

OTHER

lead

Qiu Ye

OTHER